Compared to the placebo group, in the liraglutide group the body weight reduced significantly, and up to 40% mice recovered regular estrous cycles, but testosterone levels were only slightly decreased and the reduction in fasting insulin was not statistically significant
Semaglutide targets one receptor (GLP-1), while tirzepatide targets two receptors (GLP-1 and GIP)
Research peptides havent, which means youre assuming more risk even with quality products
We do have long-term safety data for GLP-1 agonists like Ozempic, says Rehman Sheikh, a gastroenterologist at Baylor College of Medicine
Investigations persist into innovative delivery methods and formulations that may improve absorption, prolong duration of effect, or provide alternate routes of administration
Access to GLP-1 peptides has expanded significantly in Canada, yet not all patients benefit equally from the same formulation or dose